These results indicate that COL11A1 is an important regulatory factor in the occurrence and development of breast cancer, and even COL11A1 may be an independent prognostic biomarker of breast cancer, which has the value as a potential target for diagnosis, treatment and prognostic evaluation of breast cancer. This evidence concerns the gene COL11A1 and breast carcinoma.